What is Biogen's note payable to directv?

Biogen (BIIB) reported note payable to directv of $2.55B in Q1 2026.

How has Biogen's note payable to directv changed year-over-year?

Biogen's note payable to directv increased by 0.6% year-over-year, from $2.53B to $2.55B.

What is the long-term trend for Biogen's note payable to directv?

Over 5 years (2020 to 2025), Biogen's note payable to directv has grown at a -2.3% compound annual growth rate (CAGR), from $3.15B to $2.80B.

What does note payable to directv mean?

A short-term debt obligation owed to a specific business partner or related entity.

Discontinued — last reported Q2 '18

Current Liabilities

Note payable to DIRECTV

Biogen Note payable to DIRECTV decreased by 9.1% to $2.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $2.53B to $2.55B. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows a downward trend with a -2.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalLower is better

VolatilityStable

First reportedQ4 2017

Last reportedQ2 2018

How to read this metric

An increase suggests higher short-term debt reliance, while a decrease indicates the company is successfully paying down specific contractual obligations.

Detailed definition

This represents a short-term financial obligation owed to a specific corporate entity, categorized as a current liabilit...

Peer comparison

Similar to other 'Notes Payable' or 'Accounts Payable to Related Parties' found in the current liabilities section of peer balance sheets.

Metric ID: note_payable_directv

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$2.74B	$2.55B	$2.54B	$2.23B	$3.30B	$3.31B	$2.52B	$2.29B	$2.48B	$3.84B	$2.62B	$2.35B	$2.47B	$2.76B	$2.81B	$2.53B	$2.66B	$2.77B	$2.80B	$2.55B
QoQ Change	—	-6.9%	-0.6%	-12.0%	+47.8%	+0.2%	-23.7%	-9.2%	+8.4%	+54.7%	-31.6%	-10.3%	+5.0%	+11.4%	+1.9%	-9.9%	+5.1%	+4.3%	+1.0%	-9.1%
YoY Change	—	—	—	—	+20.3%	+29.6%	-0.5%	+2.6%	-24.8%	+16.1%	+4.1%	+2.9%	-0.4%	-28.2%	+7.0%	+7.5%	+7.6%	+0.7%	-0.2%	+0.6%

Range$2.23B – $3.84B

CAGR-1.5%

Avg YoY Growth+2.8%

Median YoY Growth+2.7%

Note payable to DIRECTV at Other Companies

Eli LillyLLY View metric

Royalty PharmaRPRX View metric

Roivant SciencesROIV View metric

ViatrisVTRS View metric

MedtronicMDT View metric

United TherapeuticsUTHR View metric

Frequently Asked Questions

What is Biogen's note payable to directv?: Biogen (BIIB) reported note payable to directv of $2.55B in Q1 2026.
How has Biogen's note payable to directv changed year-over-year?: Biogen's note payable to directv increased by 0.6% year-over-year, from $2.53B to $2.55B.
What is the long-term trend for Biogen's note payable to directv?: Over 5 years (2020 to 2025), Biogen's note payable to directv has grown at a -2.3% compound annual growth rate (CAGR), from $3.15B to $2.80B.
What does note payable to directv mean?: A short-term debt obligation owed to a specific business partner or related entity.